BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Collins DA, Sohn KM, Wu Y, Ouchi K, Ishii Y, Elliott B, Riley TV, Tateda K; Clostridioides difficile Asia-Pacific Study Group. Clostridioides difficile infection in the Asia-Pacific region. Emerg Microbes Infect 2020;9:42-52. [PMID: 31873046 DOI: 10.1080/22221751.2019.1702480] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dziewiecka H, Buttar HS, Kasperska A, Ostapiuk-Karolczuk J, Domagalska M, Cichoń J, Skarpańska-Stejnborn A. Physical activity induced alterations of gut microbiota in humans: a systematic review. BMC Sports Sci Med Rehabil 2022;14:122. [PMID: 35799284 DOI: 10.1186/s13102-022-00513-2] [Reference Citation Analysis]
2 Waker E, Ambrozkiewicz F, Kulecka M, Paziewska A, Skubisz K, Cybula P, Targoński Ł, Mikula M, Walewski J, Ostrowski J. High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years. Front Microbiol 2020;11:1618. [PMID: 32793147 DOI: 10.3389/fmicb.2020.01618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Tateda K, Ishida J, Ito S, Gonzalez E, Yoshizumi S, Zhang P, Pride M, Gray S, Ferreira CM, Minarovic N, Angulo FJ, Moïsi JC, Jodar L; CLOUD Study Working Group. Population-based incidence of hospitalized Clostridioides difficile infection among older adults in Ota-ku, Japan: A prospective surveillance study. Anaerobe 2022;:102607. [PMID: 35787452 DOI: 10.1016/j.anaerobe.2022.102607] [Reference Citation Analysis]
4 Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol 2021;14:17562848211016248. [PMID: 34093740 DOI: 10.1177/17562848211016248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ramos CP, Diniz AN, Ribeiro MG, de Paula CL, Costa ÉA, Sonne L, Pereira ST, Lopes CEB, Rennó MC, Silva ROS. Enteric Organisms Detected in Feces of Dogs With Bloody Diarrhea: 45 Cases. Top Companion Anim Med 2021;45:100549. [PMID: 34044173 DOI: 10.1016/j.tcam.2021.100549] [Reference Citation Analysis]
6 Guo CLT, Kwong TNY, Mak JWY, Zhang L, Lui GCY, Wong GLH, Ip M, Yu J, Sung JJY, Wu WKK, Wong SH. Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong. Emerg Infect Dis 2021;27. [PMID: 34812719 DOI: 10.3201/eid2712.203769] [Reference Citation Analysis]
7 Haifer C, Paramsothy S, Borody TJ, Clancy A, Leong RW, Kaakoush NO. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection. mSystems 2021;6:e00905-20. [PMID: 33531405 DOI: 10.1128/mSystems.00905-20] [Reference Citation Analysis]
8 Collins DA, Wu Y, Tateda K, Kim HJ, Vickers RJ, Riley TV. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile. J Antimicrob Chemother 2021;76:967-72. [PMID: 33351917 DOI: 10.1093/jac/dkaa522] [Reference Citation Analysis]
9 Lim SC, Hain-Saunders NMR, Imwattana K, Putsathit P, Collins DA, Riley TV. Genetically related Clostridium difficile from water sources and human CDI cases revealed by whole-genome sequencing. Environ Microbiol 2021. [PMID: 34693624 DOI: 10.1111/1462-2920.15821] [Reference Citation Analysis]
10 Ye J, Chu AJ, Lin L, Chan ST, Harper R, Xiao M, Artsimovitch I, Zuo Z, Ma C, Yang X. Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction. Eur J Med Chem 2020;208:112671. [PMID: 32920341 DOI: 10.1016/j.ejmech.2020.112671] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Khun PA, Phi LD, Pham PT, Thu Nguyen HT, Huyen Vu QT, Collins DA, Riley TV. Clostridioides (Clostridium) difficile in children with diarrhoea in Vietnam. Anaerobe 2022;:102550. [PMID: 35331913 DOI: 10.1016/j.anaerobe.2022.102550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Amirkamali S, Azimirad M, Nasiri G, Goudarzi H, Noori M, Yadegar A, Ghalavand Z, Zali MR. Surface layer protein A from hypervirulent Clostridioides difficile ribotype 001 can induce autophagy process in human intestinal epithelial cells. Microb Pathog 2022;169:105681. [PMID: 35850375 DOI: 10.1016/j.micpath.2022.105681] [Reference Citation Analysis]
13 Tai AS, Putsathit P, Eng L, Imwattana K, Collins DA, Mulrennan S, Riley TV. Clostridioides difficile colonization and infection in a cohort of Australian adults with cystic fibrosis. J Hosp Infect 2021;113:44-51. [PMID: 33775742 DOI: 10.1016/j.jhin.2021.03.018] [Reference Citation Analysis]
14 Li Z, Ke H, Lin Q, Shen Z, Chen Y. Global trends in gut microbiota and clostridioides difficile infection research: A visualized study. J Infect Public Health 2022;15:806-15. [PMID: 35759806 DOI: 10.1016/j.jiph.2022.06.011] [Reference Citation Analysis]
15 Kim N, Lee SY, Park J, Lee J. Comparative Evaluation of Three Immunoassays for the Simultaneous Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxin A/B. Microorganisms 2022;10:947. [DOI: 10.3390/microorganisms10050947] [Reference Citation Analysis]
16 Lew T, Putsathit P, Sohn KM, Wu Y, Ouchi K, Ishii Y, Tateda K, Riley TV, Collins DA. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015. Antimicrob Agents Chemother 2020;64:e00296-20. [PMID: 32393487 DOI: 10.1128/AAC.00296-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wen X, Shen C, Xia J, Zhong LL, Wu Z, Ahmed MAEE, Long N, Ma F, Zhang G, Wu W, Luo J, Xia Y, Dai M, Zhang L, Liao K, Feng S, Chen C, Chen Y, Luo W, Tian GB. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study. Microbiol Spectr 2022;:e0132221. [PMID: 35019676 DOI: 10.1128/spectrum.01322-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang WZ, Li WG, Liu YQ, Gu WP, Zhang Q, Li H, Liu ZJ, Zhang X, Wu Y, Lu JX. The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China. BMC Microbiol 2020;20:70. [PMID: 32228454 DOI: 10.1186/s12866-020-01757-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Senoh M, Kato H. Molecular epidemiology of endemic Clostridioides difficile infection in Japan. Anaerobe 2022. [DOI: 10.1016/j.anaerobe.2021.102510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kiersnowska ZM, Lemiech-Mirowska E, Sierocka A, Zawadzki M, Michałkiewicz M, Marczak M. Application of a Novel PM Model to Assess the Risk of Clostridioides difficile Infections in Medical Facilities as a Tool for Improving the Quality of Health Services and the Safety of Patients. Int J Environ Res Public Health 2021;19:441. [PMID: 35010698 DOI: 10.3390/ijerph19010441] [Reference Citation Analysis]
21 Li F, Jiang L, Pan S, Jiang S, Fan Y, Jiang C, Gao C, Leng Y, David LA. Multi-omic Profiling Reveals that Intra-abdominal-Hypertension-Induced Intestinal Damage Can Be Prevented by Microbiome and Metabolic Modulations with 5-Hydroxyindoleacetic Acid as a Diagnostic Marker. mSystems. [DOI: 10.1128/msystems.01204-21] [Reference Citation Analysis]
22 Abdrabou AMM, Bischoff M, Mellmann A, von Müller L, Margardt L, Gärtner BC, Berger FK, Haase G, Häfner H, Hoffmann R, Simon V, Stappmanns H, Hischebeth GT, Büchler C, Rößler S, Hochauf-stange K, Pfeffer K, Mackenzie C, Kunz C, Alsalameh R, Dziobaka J, le Chapot VS, Sanabria E, Hogardt M, Komp J, Imirzalioglu C, Schmiedel J, Pararas M, Sommer F, Groß U, Bohne W, Kekulé AS, Dagwadordsch U, Löffler B, Rödel J, Walker SV, Tobys D, Weikert-asbeck S, Hauswaldt S, Kaasch AJ, Zautner AE, Joß N, Siegel E, Kehr K, Schaumburg F, Schoeler S, Hamprecht A, Hellkamp J, Hagemann JB, Kubis J, Hering S, Warnke P. Implementation of a Clostridioides difficile sentinel surveillance system in Germany: First insights for 2019–2021. Anaerobe 2022. [DOI: 10.1016/j.anaerobe.2022.102548] [Reference Citation Analysis]